Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prospective audit of the introduction of insulin glargine (lantus) into clinical practice in type 1 diabetic patients.

× No keyword cloud information.

6 in total

1. From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a 'routine' diabetes clinic?

Authors: L A Distiller; B I Joffe
Journal: Diabetologia Date: 2006-09-19 Impact factor: 10.122

2. In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes.

Authors: Xing-Wei Wong; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; Jessica Lin; Aaron J Le Compte; Geoffrey M Shaw
Journal: J Diabetes Sci Technol Date: 2008-05

Review 3. Insulin glargine in the treatment of type 1 and type 2 diabetes.

Authors: Anthony H Barnett
Journal: Vasc Health Risk Manag Date: 2006

4. Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications.

Authors: Paulo H R F Almeida; Thales B C Silva; Francisco de Assis Acurcio; Augusto A Guerra Júnior; Vania E Araújo; Leonardo M Diniz; Brian Godman; Alessandra M Almeida; Juliana Alvares
Journal: Patient Date: 2018-08 Impact factor: 3.883

5. Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.

Authors: Peter Sharplin; Jason Gordon; John R Peters; Anthony P Tetlow; Andrea J Longman; Philip McEwan
Journal: Cardiovasc Diabetol Date: 2009-02-16 Impact factor: 9.951

6. Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study.

Authors: Peter Sharplin; Jason Gordon; John R Peters; Anthony P Tetlow; Andrea J Longman; Philip McEwan
Journal: Cardiovasc Diabetol Date: 2009-01-19 Impact factor: 9.951

6 in total